Treatment of Inflammatory pain using IL-20 Antagonists

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Reducing inflammatory pain in a subject having or being suspected of having an inflammatory pain using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.
Original languageEnglish
Patent number9376490
Publication statusPublished - 1800

Fingerprint

Pain
Anti-Idiotypic Antibodies
Antibodies
Therapeutics
interleukin 20

Cite this

@misc{0799e65a618e435083b319fe7048e82f,
title = "Treatment of Inflammatory pain using IL-20 Antagonists",
abstract = "Reducing inflammatory pain in a subject having or being suspected of having an inflammatory pain using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "9376490",

}

TY - PAT

T1 - Treatment of Inflammatory pain using IL-20 Antagonists

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - Reducing inflammatory pain in a subject having or being suspected of having an inflammatory pain using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

AB - Reducing inflammatory pain in a subject having or being suspected of having an inflammatory pain using an IL-20 antagonist, which can be an antibody that blocks a signaling pathway mediated by IL-20. Such antibodies include anti-IL-20 antibodies and anti-IL-20R antibodies that specifically block the IL-20 signaling pathway.

M3 - Patent

M1 - 9376490

ER -